UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 607

Sortiert nach

Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

Annals of oncology, 2022-05, Vol.33 (5), p.500-510

2022

Link zum Volltext

Verfügbarkeit prüfen

Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858

Leukemia, 2017-10, Vol.31 (10), p.2172-2180

2017

Link zum Volltext

Verfügbarkeit prüfen

CD44 variant exon epitopes in primary breast cancer and length of survival

The Lancet (British edition), 1995-03, Vol.345 (8950), p.615-619

1995

Link zum Volltext

Verfügbarkeit prüfen

Action of novel CD37 antibodies on chronic lymphocytic leukemia cells

Leukemia, 2012-03, Vol.26 (3), p.546-549

2012

Link zum Volltext

Verfügbarkeit prüfen

TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis

Current biology, 1998-11, Vol.8 (23), p.1243-1252

1998

Link zum Volltext

Verfügbarkeit prüfen

Whom are we treating with adaptive servo-ventilation? A clinical post hoc analysis

Clinical research in cardiology, 2017-09, Vol.106 (9), p.702-710

2017

Link zum Volltext

Verfügbarkeit prüfen

Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment

Blood cancer journal (New York), 2016-11, Vol.6 (11), p.e496-e496

2016

Link zum Volltext

Verfügbarkeit prüfen

Polycation-based DNA complexes for tumor-targeted gene delivery in vivo

The journal of gene medicine, 1999-03, Vol.1 (2), p.111-120

1999

Link zum Volltext

Verfügbarkeit prüfen

The Cultural Context of Emotion: Folk Psychology in West Sumatra

Heider, K

1st ed., 2011

Link zum Volltext

Verfügbarkeit prüfen

CD44v6: a target for antibody-based cancer therapy

Cancer Immunology, Immunotherapy, 2004-07, Vol.53 (7), p.567-579

2004

Link zum Volltext

Verfügbarkeit prüfen

Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44

The Journal of experimental medicine, 1993-04, Vol.177 (4), p.897-904

1993

Link zum Volltext

Verfügbarkeit prüfen

A Human Homologue of the Rat Metastasis-Associated Variant of CD44 Is Expressed in Colorectal Carcinomas and Adenomatous Polyps

The Journal of cell biology, 1993-01, Vol.120 (1), p.227-233

1993

Link zum Volltext

Verfügbarkeit prüfen

Comparison of immunohistochemistry and RT‐PCR for detection of CD44v‐expression, a new prognostic factor in human breast cancer

International journal of cancer, 1995-02, Vol.60 (4), p.471-477

1995

Link zum Volltext

Verfügbarkeit prüfen

Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium

Cancer research (Chicago, Ill.), 1994-07, Vol.54 (13), p.3337-3341

1994

Link zum Volltext

Verfügbarkeit prüfen

Image Subset Selection Using Gabor Filters and Neural Networks

International journal of multimedia & its applications, 2015-04, Vol.7 (2), p.43-55

2015

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

The lancet oncology, 2015-08, Vol.16 (8), p.979-989

2015

Link zum Volltext

Verfügbarkeit prüfen

379MO Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Updated results from BEGONIA, a phase Ib/II study

Annals of oncology, 2023-10, Vol.34, p.S337-S337

2023

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa

Cancer research (Chicago, Ill.), 1993-09, Vol.53 (18), p.4197-4203

1993

Link zum Volltext

Verfügbarkeit prüfen

Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer

The Journal of pathology, 1997-10, Vol.183 (2), p.222-227

1997

Link zum Volltext

Verfügbarkeit prüfen

Visual Research and Indonesian Ethnography: Beyond Description

Heider, Karl G.

1, 2021

Link zum Volltext

Verfügbarkeit prüfen

57P Immune-mediated adverse event (imAE) incidence, timing and association with efficacy in the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in advanced biliary tract cancer (BTC)

Annals of oncology, 2022-09, Vol.33, p.S566-S567

2022

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas

Cancer Immunology, Immunotherapy, 1996-12, Vol.43 (4), p.245-253

1996

Link zum Volltext

Verfügbarkeit prüfen

Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn’s disease

Gut, 1998-09, Vol.43 (3), p.375-382

1998

Link zum Volltext

Verfügbarkeit prüfen

Expression of CD44 isoforms in human skin cancer

European journal of cancer (1990), 1996-07, Vol.32 (8), p.1394-1400

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 607

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(425)
Mit Volltextzugriff
(528)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858

CD44 variant exon epitopes in primary breast cancer and length of survival

Action of novel CD37 antibodies on chronic lymphocytic leukemia cells

TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis

Whom are we treating with adaptive servo-ventilation? A clinical post hoc analysis

Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment

Polycation-based DNA complexes for tumor-targeted gene delivery in vivo

The Cultural Context of Emotion: Folk Psychology in West Sumatra

CD44v6: a target for antibody-based cancer therapy

Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44

A Human Homologue of the Rat Metastasis-Associated Variant of CD44 Is Expressed in Colorectal Carcinomas and Adenomatous Polyps

Comparison of immunohistochemistry and RT‐PCR for detection of CD44v‐expression, a new prognostic factor in human breast cancer

Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium

Image Subset Selection Using Gabor Filters and Neural Networks

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

379MO Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Updated results from BEGONIA, a phase Ib/II study

Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa

Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer

Visual Research and Indonesian Ethnography: Beyond Description

57P Immune-mediated adverse event (imAE) incidence, timing and association with efficacy in the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in advanced biliary tract cancer (BTC)

Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas

Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn’s disease

Expression of CD44 isoforms in human skin cancer

Suchergebnisse filtern